指南与共识免疫规划卫生政策与健康促进

临床医生对性少数与性别少数患者HPV疫苗接种建议的自我报告

Clinicians' self-reported HPV vaccination recommendations for sexual and gender minority patients.
指南 / 共识 · Vaccine · 2026-08-14

2024年美国全国横断面调查纳入483名基层临床医生,用6个性取向、出生性别与性别认同各异的临床情景案例评估HPV疫苗接种建议。无论患者特征如何,59-69%报告会始终推荐HPV疫苗,9-19%报告多数时候推荐,且多数医生在不同情景间推荐可能性高度一致。高级实践提供者、女性医生及非西班牙裔白人医生报告推荐可能性更高。

要点

  • 多数临床医生对性少数与性别少数患者推荐HPV疫苗的可能性较高。
  • 推荐可能性在不同患者性取向、性别认同间差异很小。
  • 高级实践提供者、女性及非西班牙裔白人医生推荐可能性更高。

核心结论

  • 参与者普遍报告对性少数与性别少数患者推荐HPV疫苗的可能性较高,且推荐几乎不因患者性别、性取向或性别认同而变化。

研究设计与样本

  • 2024年美国全国横断面调查,对象为基层临床医生(医师与高级实践提供者),样本量n=483。
  • 参与者回答6个临床情景案例,案例在患者性取向、出生性别与性别认同上有所不同。

主要发现

  • 在所有情景中,无论患者特征如何,59-69%报告会始终推荐HPV疫苗,9-19%报告多数时候(50-79%的时间)推荐。
  • 绝大多数参与者在不同情景间推荐可能性高度一致。
  • 高级实践提供者较医师推荐可能性更高(p=0.016)。
  • 女性临床医生较男性推荐可能性更高(p<0.001)。
  • 非西班牙裔白人临床医生较其他种族/族裔组推荐可能性更高(p=0.006)。

临床怎么用

  • 基层临床医生应保持对所有患者(包括性少数与性别少数人群)一致的高HPV疫苗接种推荐。
  • 针对医师、男性及少数族裔临床医生可加强HPV疫苗推荐相关培训。

局限性

  • 样本以非西班牙裔(93%)、白人(74%)、医师(56%)为主,且70%不在农村/边疆社区执业,代表性有限。
  • 结果为医生自我报告,可能与实际推荐行为存在差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: There are multiple human papillomavirus (HPV)-related disparities experienced by sexual and gender minority (SGM) populations in the United States (U.S.), including higher rates of some HPV-associated cancers, lower rates of HPV vaccination among certain subgroups, and higher rates of healthcare discrimination. METHODS: We conducted a national cross-sectional survey of U.S. primary care clinicians (physicians and advanced practice providers [APPs]) in 2024 to examine HPV vaccination recommendation practices for SGM patients. Participants responded to a series of six clinical vignettes which varied by patients' sexual orientation, sex assigned at birth, and gender identity. RESULTS: The sample (n = 483) was primarily non-Hispanic (93%), White (74%), physicians (56%), and did not practice in a rural/frontier community (70%). Across the vignettes, regardless of patient characteristics, 59-69% reported they would always recommend the HPV vaccine; whereas 9-19% reported they would recommend the HPV vaccine often (50-79% of the time). The vast majority were highly consistent in recommendation likelihood across vignettes. Greater likelihood of recommending the HPV vaccine was observed for APPs versus physicians (p = 0.016), female clinicians versus males (p < 0.001), and non-Hispanic White clinicians versus other racial/ethnic groups (p = 0.006). CONCLUSIONS: In summary, participants generally reported high likelihood of recommending the HPV vaccine, with recommendations differing very little by patient sex, sexual orientation, or gender identity.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kasting ML, Sutton SK, Davish M, et al. Clinicians' self-reported HPV vaccination recommendations for sexual and gender minority patients. Vaccine. 2026. PMID: 42600245. doi:10.1016/j.vaccine.2026.129037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。